Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, C. E. Masse, Shulu Feng et al.|Journal of Medicinal Chemistry|2023Cited by 60
Abstract 2894: NTX-452: a non-covalent, potent, selective and highly efficacious WRN inhibitor with best-in-class potential for the treatment of MSI-H tumorsRobert Svensson, Peter J. Tummino, Scott Boiko et al.|Cancer Research|2025Cited by 5
Abstract 589: Discovery of NTX-001, a potent Cbl-b inhibitor with antitumor activity in syngeneic modelsFred Csibi-Levin, David Ciccone, Silvana Leit et al.|Cancer Research|2022Cited by 1
356 (PB344): Preclinical characterization of NTX-452, a potent, selective and highly efficacious WRN inhibitor for the treatment of MSI-H tumorsScott Boiko, Robert Svensson, Di Li et al.|European Journal of Cancer|2024Cited by 0
Knowledge andStructure-Based Drug Design of 15-PGDHInhibitorsLeela S. Dodda, Neelu Kaila, Sébastien Campos et al.|Journal of Medicinal Chemistry|2025Cited by 0